| PDF (1MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-204405
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.20440
Alternative Links zum Volltext:Pubmed
Zusammenfassung
To reduce the opportunities for human immunodeficiency virus type 1 (HIV-1) to evade vaccine induced immunity, the development of subunit vaccines must focus on the characterization of immunogenic epitopes, which are major targets for the immune system. The most dominant site for elicitation of neutralising immune response is located on the external envelope glycoprotein gp120 within the third ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik